The Royal Shrewsbury Hospital is a teaching hospital in Shrewsbury, Shropshire, England. It forms the Shrewsbury site of the Shrewsbury and Telford Hospital NHS Trust, serving patients from Shropshire and Powys, in conjunction with the Princess Royal Hospital in Telford.

There are 492 beds in Royal Shrewsbury Hospital.

During the past decade, Royal Shrewsbury Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 13 clinical trials were completed, i.e. on average, 68.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Shrewsbury Hospital" #1 sponsor was "Celgene" with 7 trials, followed by "Institute of Cancer Research, United Kingdom" with 6 trials sponsored, "Medical Research Council" with 4 trials sponsored, "Shire" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Shrewsbury Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Royal Shrewsbury Hospital" are "Breast Cancer" (8 trials), "Ulcerative Colitis" (5 trials), "Crohn Disease" (4 trials), "Crohn's Disease" (4 trials) and "Ovarian Cancer" (4 trials). Many other conditions were trialed in "Royal Shrewsbury Hospital" in a lesser frequency.

Most popular intervention types in "Royal Shrewsbury Hospital" are "Drug" (40 trials), "Other" (10 trials), "Procedure" (9 trials), "Radiation" (7 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "adjuvant therapy" (5 trials), "radiation therapy" (5 trials), "Ozanimod" (3 trials) and "carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Royal Shrewsbury Hospital" are 41 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Shrewsbury Hospital". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Royal Shrewsbury Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Shrewsbury Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".